Beta-like hippocampal network activity is differentially affected by amyloid beta peptides

Peptides

Volumn 31, Issue 9, 2010, Pages 1761-1766

  Adaya Villanueva, Alvaro ^a   Ordaz, Benito ^a   Balleza Tapia, Hugo ^a   Márquez Ramos, Abraham ^a   Peña Ortega, Fernando ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Alzheimer's disease; Amyloid beta protein; Kainate receptors; Network activity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; KAINIC ACID; KAINIC ACID RECEPTOR; POTASSIUM;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GAMMA RHYTHM; HIPPOCAMPUS; NERVE CELL NETWORK; NONHUMAN; OLIGOMERIZATION; OSCILLATION; PRIORITY JOURNAL; RAT; THETA RHYTHM;

EID: 77955654861     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.06.003     Document Type: Article

References (50)

1. Baglietto-Vargas D, Moreno-Gonzalez I, Sanchez-Varo R, Jimenez S, Trujillo-Estrada L, Sanchez-Mejias E, et al. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus. J Alzheimers Dis in press.
2. H. Balleza-Tapia, and F. Peña Pharmacology of the intracellular pathways activated by amyloid beta protein Mini Rev Med Chem 9 2009 724 740
3. Balleza-Tapia H, Arias N, Peña F. Amyloid β oligomers decrease hippocampal spontaneous activity in an age-dependent manner. Curr Alzheimer Res in press.
4. J.T. Brown, A. Teriakidis, and A.D. Randall A pharmacological investigation of the role of GLUK5-containing receptors in kainate-driven hippocampal gamma band oscillations Neuropharmacology 50 2006 47 56
5. L.V. Colom, M.T. Castañeda, C. Bañuelos, G. Puras, A. García-Hernández, and S. Hernandez Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function Neurobiol Aging 31 2008 46 57
6. S. Delobette, A. Privat, and T. Maurice In vitro aggregation facilities beta-amyloid peptide- (25-35)-induced amnesia in the rat Eur J Pharmacol 319 1997 1 4
7. J.E. Driver, C. Racca, M.O. Cunningham, S.K. Towers, C.H. Davies, and M.A. Whittington Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP) Eur J Neurosci 26 2007 1280 1288
8. A. Fisahn, A. Contractor, R.D. Traub, E.H. Buhl, S.F. Heinemann, and C.J. McBain Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations J Neurosci 24 2004 9658 9668
9. D.B. Freir, and C.E. Herron Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo J Neurophysiol 89 2003 2917 2922
10. D.B. Freir, D.A. Costello, and C.E. Herron A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil J Neurophysiol 89 2003 3061 3069
11. S. Gengler, V.A. Gault, P. Harriott, and C. Hölscher Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background Exp Brain Res 179 2007 621 630
12. E.A. Grace, C.A. Rabiner, and J. Busciglio Characterization of neuronal dystrophy induced by fibrillar amyloid b: implications for Alzheimer's disease Neuroscience 114 2002 265 273
13. M.A. Gruden, T.B. Davidova, M. Malisauskas, R.D. Sewell, N.I. Voskresenskaya, and K. Wilhelm Differential neuroimmune markers to the onset of Alzheimer disease neurodegeneration and dementia: autoantibodies to Abeta ((25-35)) oligomers, S100b and neurotransmitters J Neuroimmunol 186 2007 181 192
14. N. Hájos, I. Katona, S.S. Naiem, K. MacKie, C. Ledent, and I. Mody Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations Eur J Neurosci 12 2000 3239 3249
15. D. Hermann, M. Both, U. Ebert, G. Gross, H. Schoemaker, and A. Draguhn Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes Neuroscience 162 2009 1081 1090
16. C.S. Herrmann, M.H. Munk, and A.K. Engel Cognitive functions of gamma-band activity: memory match and utilization Trends Cogn Sci 8 2004 347 355
17. H. Hiruma, T. Katakura, S. Takahashi, T. Ichikawa, and T. Kawakami Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms J Neurosci 23 2003 8967 8977
18. C. Holscher, S. Gengler, V.A. Gault, P. Harriott, and H.A. Mallot Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning Eur J Pharmacol 561 2007 85 90
19. J.R. Hughes, S. Shanmugham, L.C. Wetzel, S. Bellur, and C.A. Hughes The relationship between EEG changes and cognitive functions in dementia: a study in a VA population Clin Electroencephalogr 20 1989 77 85
20. I. Kaneko, K. Morimoto, and T. Kubo Drastic neuronal loss in vivo by beta-amyloid racemized at Ser (26) residue: conversion of nontoxic [D-Ser (26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments Neuroscience 104 2001 1003 1011
21. A.R. Korotzer, E.R. Whittemore, and C.W. Cotman Differential regulation by beta-amyloid peptides of intracellular free Ca2+ concentration in cultured rat microglia Eur J Pharmacol 288 1995 125 130
22. J.W. Kowalski, M. Gawel, A. Pfeffer, and M. Barcikowska The diagnosticvalue of EEG in Alzheimer disease: correlation with the severity of mental impairment J Clin Neurophysiol 18 2001 570 575
23. T. Kubo, S. Nishimura, Y. Kumagae, and I. Kaneko In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients J Neurosci Res 70 2002 474 483
24. F.E. LeBeau, S.K. Towers, R.D. Traub, M.A. Whittington, and E.H. Buhl Fast network oscillations induced by potassium transients in the rat hippocampus in vitro J Physiol 542 2002 167 179
25. T. Maurice, B.P. Lockhart, and A. Privat Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction Brain Res 706 1996 181 193
26. C. Nerelius, A. Sandegren, H. Sargsyan, R. Raunak, H. Leijonmarck, and U. Chatterjee Alpha-helix targeting reduces amyloid-beta peptide toxicity Proc Natl Acad Sci USA 106 2009 9191 9196
27. J. Pálhalmi, O. Paulsen, T.F. Freund, and N. Hájos Distinct properties of carbachol-and DHPG-induced network oscillations in hippocampal slices Neuropharmacology 47 2004 381 389
28. J.J. Palop, J. Chin, E.D. Roberson, J. Wang, M.T. Thwin, and N. Bien-Ly Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease Neuron 55 2007 697 711
29. F. Peña, and N. Alavez-Pérez Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro Epilepsia 47 2006 47 54
30. F. Peña, A. Gutiérrez-Lerma, R. Quiroz-Baez, and C. Arias The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy Curr Neuropharmacol 4 2006 149 163
31. F. Peña, B. Ordaz, H. Balleza-Tapia, R. Bernal-Pedraza, A. Márquez-Ramos, and L. Carmona-Aparicio Beta-amyloid protein (25-35) disrupts hippocampal network activity: role of FYN-kinase Hippocampus 20 1 2010 78 96
32. C.J. Pike, A.J. Walencewicz-Wasserman, J. Kosmoski, D.H. Cribbs, C.G. Glabe, and C.W. Cotman Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity J Neurochem 64 1995 253 265
33. J.M. Ramirez, A.K. Tryba, and F. Peña Pacemaker neurons and neuronal networks: an integrative view Curr Opin Neurobiol 14 2004 665 674
34. R. Rönicke, A. Klemm, J. Meinhardt, U.H. Schröder, M. Fändrich, and K.G. Reymann Abeta mediated diminution of MTT reduction - an artefact of single cell culture? PloS One 3 2008 e3236
35. Y. Rui, R. Li, Y. Liu, S. Zhu, X. Yu, and Z. Sheng Acute effect of beta amyloid on synchronized spontaneous Ca2+ oscillations in cultured hippocampal networks Cell Biol Int 30 2006 733 740 (Pubitemid 44331631)
36. A.W. Schmid, D.B. Freir, and C.E. Herron Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states Brain Res 1197 2008 135 142
37. U. Schreiter-Gasser, T. Gasser, and P. Ziegler Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity clinical characteristics visual EEG, CCT Electroencephalogr Clin Neurophysiol 90 1994 267 272
38. P.B. Sederberg, M.J. Kahana, M.W. Howard, E.J. Donner, and J.R. Madsen Theta and gamma oscillations during encoding predict subsequent recall J Neurosci 23 2003 10809 10814
39. J.P. Smith, V. Lal, D. Bowser, R. Cappai, C.L. Masters, and G.D. Ciccotosto Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices Brain Res 1269 2009 176 184
40. M.Y. Stepanichev, I.M. Zdobnova, I.I. Zarubenko, Y.V. Moiseeva, N.A. Lazareva, and M.V. Onufriev Amyloid-beta (25-35)-induced memory impairments correlate with cell loss in rat hippocampus Physiol Behav 80 2004 647 655
41. M.K. Sun, and D.L. Alkon Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid (25-35) J Neurophysiol 87 2002 2441 2449
42. C. Tohda, N. Matsumoto, K. Zou, M.R. Meselhy, and K. Komatsu Abeta (25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins Neuropsychopharmacology 29 2004 860 868
43. S.K. Towers, F.E. LeBeau, T. Gloveli, R.D. Traub, M.A. Whittington, and E.H. Buhl Fast network oscillations in the rat dentate gyrus in vitro J Neurophysiol 87 2002 1165 1168
44. R.D. Traub, N. Spruston, I. Soltesz, A. Konnerth, M.A. Whittington, and G.R. Jefferys Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity Prog Neurobiol 55 1998 563 575
45. R.D. Traub, A. Bibbig, F.E. LeBeau, E.H. Buhl, and M.A. Whittington Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro Annu Rev Neurosci 27 2004 247 278
46. S. Varadarajan, J. Kanski, M. Aksenova, C. Lauderback, and D.A. Butterfield Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta (1-42) and A beta (25-35) J Am Chem Soc 123 2001 5625 5631
47. P.J. Welsby, M.J. Rowan, and R. Anwyl Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP Neuropharmacology 53 2007 188 195
48. M.A. Whittington, H.J. Faulkner, H.C. Doheny, and R.D. Traub Neuronal fast oscillations as a target site for psychoactive drugs Pharmacol Ther 86 2000 171 190
49. Y. Yamaguchi, and S. Kawashima Effects of amyloid-beta- (25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat Eur J Pharmacol 412 2001 265 272 (Pubitemid 32144942)
50. B.A. Yanker, L.K. Duffy, and D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 1990 279 282